Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial.

Name: Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial.
Author: Koskinas, Konstantinos C

Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial. — المؤلف: Koskinas, Konstantinos C — Clinical cardiology 20190419

المؤلف: Koskinas, Konstantinos C
النشر: Clinical cardiology 20190419
الوصف: 1513-1520 p.
الموضوعات: Acute Coronary Syndrome؛ Antibodies, Monoclonal؛ Antibodies, Monoclonal, Humanized؛ Anticholesteremic Agents؛ Biomarkers؛ Cholesterol, LDL؛ Dose-Response Relationship, Drug؛ Double-Blind Method